Genetic Determinants of the Interventricular Septum Are Linked to Ventricular Septal Defects and Hypertrophic Cardiomyopathy

被引:4
|
作者
Yu, Mengyao [2 ,4 ]
Harper, Andrew R. [6 ,7 ,8 ]
Aguirre, Matthew [2 ,9 ]
Pittman, Maureen [10 ,11 ]
Tcheandjieu, Catherine [2 ,3 ,4 ]
Amgalan, Dulguun [5 ,12 ]
Grace, Christopher [6 ,7 ]
Goel, Anuj [6 ,7 ]
Farrall, Martin [6 ,7 ]
Xiao, Ke [13 ]
Engreitz, Jesse [5 ,12 ]
Pollard, Katherine S. [10 ,11 ,14 ]
Watkins, Hugh [6 ,7 ]
Priest, James R. [1 ,2 ,4 ,14 ,15 ]
机构
[1] Tenaya Therapeut, 171 Oyster Point Blvd,Suite 500, South San Francisco, CA 94080 USA
[2] Stanford Univ, Dept Pediat, Div Pediat Cardiol, Sch Med, Stanford, CA USA
[3] Stanford Univ, Dept Med, Div Cardiovasc Med, Sch Med, Stanford, CA USA
[4] Stanford Cardiovasc Inst, Stanford, CA USA
[5] Stanford Univ, Dept Genet, Stanford, CA USA
[6] Univ Oxford, John Radcliffe Hosp, Radcliffe Dept Med, Div Cardiovasc Med, Oxford, England
[7] Wellcome Ctr Human Genet, Roosevelt Dr, Oxford, England
[8] AstraZeneca, Ctr Genom Res, BioPharmaceut R&D, Discovery Sci, Cambridge, England
[9] Stanford Med Sch, Dept Biomed Data Sci, Palo Alto, CA USA
[10] Univ Calif San Francisco, San Francisco, CA USA
[11] Gladstone Inst Data Sci & Biotechnol, San Francisco, CA USA
[12] Lucile Packard Childrens Hosp, Betty Irene Moore Childrens Heart Ctr, Basic Sci & Engn Initiat, Stanford, CA USA
[13] Univ Massachusetts, Coll Informat & Comp Sci, Amherst, MA USA
[14] Chan Zuckerberg Biohub, San Francisco, CA USA
[15] Tenaya Therapeut, South San Francisco, CA USA
来源
基金
美国国家卫生研究院;
关键词
chromatin; genomics; hypertrophic cardiomyopathy; magnetic resonance imaging; nucleotide; HEART; PROLIFERATION; ASSOCIATION; SUSCEPTIBILITY; VARIANTS;
D O I
10.1161/CIRCGEN.122.003708
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background:A large proportion of genetic risk remains unexplained for structural heart disease involving the interventricular septum (IVS) including hypertrophic cardiomyopathy and ventricular septal defects. This study sought to develop a reproducible proxy of IVS structure from standard medical imaging, discover novel genetic determinants of IVS structure, and relate these loci to diseases of the IVS, hypertrophic cardiomyopathy, and ventricular septal defect. Methods:We estimated the cross-sectional area of the IVS from the 4-chamber view of cardiac magnetic resonance imaging in 32 219 individuals from the UK Biobank which was used as the basis of genome wide association studies and Mendelian randomization. Results:Measures of IVS cross-sectional area at diastole were a strong proxy for the 3-dimensional volume of the IVS (Pearson r=0.814, P=0.004), and correlated with anthropometric measures, blood pressure, and diagnostic codes related to cardiovascular physiology. Seven loci with clear genomic consequence and relevance to cardiovascular biology were uncovered by genome wide association studies, most notably a single nucleotide polymorphism in an intron of CDKN1A (rs2376620; & beta;, 7.7 mm(2) [95% CI, 5.8-11.0]; P=6.0x10(-10)), and a common inversion incorporating KANSL1 predicted to disrupt local chromatin structure (& beta;, 8.4 mm(2) [95% CI, 6.3-10.9]; P=4.2x10(-14)). Mendelian randomization suggested that inheritance of larger IVS cross-sectional area at diastole was strongly associated with hypertrophic cardiomyopathy risk (p(IVW)=4.6x10(-10)) while inheritance of smaller IVS cross-sectional area at diastole was associated with risk for ventricular septal defect (p(IVW)=0.007). Conclusions:Automated estimates of cross-sectional area of the IVS supports discovery of novel loci related to cardiac development and Mendelian disease. Inheritance of genetic liability for either small or large IVS, appears to confer risk for ventricular septal defect or hypertrophic cardiomyopathy, respectively. These data suggest that a proportion of risk for structural and congenital heart disease can be localized to the common genetic determinants of size and shape of cardiovascular anatomy.
引用
收藏
页码:207 / 215
页数:9
相关论文
共 50 条
  • [41] Ablation of ventricular tachycardia after septal myectomy for hypertrophic cardiomyopathy
    Demirtas, Abdullah Orhan
    Singh, Sheldon M.
    JOURNAL OF ARRHYTHMIA, 2024, 40 (03) : 636 - 638
  • [42] "Speckled" Ventricular Septum in Hypertrophic Cardiomyopathy Revisited After 30 Years
    Maron, Barry J.
    Lindberg, Jana
    Haas, Tammy S.
    Kitner, Carrie
    Schum, Kevin
    Lesser, John R.
    Maron, Martin S.
    AMERICAN JOURNAL OF CARDIOLOGY, 2011, 107 (12): : 1862 - 1863
  • [43] Non-surgical ablation of the ventricular septum for the treatment of hypertrophic cardiomyopathy
    Knight, C
    Sigwart, U
    HEART, 1996, 76 (01) : 92 - 92
  • [44] Remodeling of the Embryonic Interventricular Communication in Regard to the Description and Classification of Ventricular Septal Defects
    Anderson, Robert H.
    Spicer, Diane E.
    Mohun, Timothy J.
    Hikspoors, Jill P. J. M.
    Lamers, Wouter H.
    ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY, 2019, 302 (01): : 19 - 31
  • [45] Selective Interventricular Septal Radiofrequency Ablation in Patients With Hypertrophic Obstructive Cardiomyopathy: Who Can Benefit?
    Liu, Qiang
    Qiu, Hangyuan
    Jiang, Ruhong
    Tang, Xiaomei
    Guo, Wenpu
    Zhou, Kuangshi
    Chen, Qiufan
    Sun, Yaxun
    Yu, Lu
    Chen, Shiquan
    Zhang, Pei
    Sheng, Xia
    Zhu, Jun
    Lin, Jianwei
    Cheng, Hui
    Wang, Yunhe
    Wang, Bei
    Yu, Chan
    Mao, Yankai
    Zhang, Juhong
    Zhang, Zuwen
    Zei, Paul C.
    Fu, Guosheng
    Jiang, Chenyang
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [46] Hydatid cyst of the interventricular septum causing complete heart block and postoperative ventricular septal defect
    Sabzi, Feridoun
    Faraji, Reza
    INDIAN JOURNAL OF CRITICAL CARE MEDICINE, 2014, 18 (07) : 473 - 475
  • [47] A Clinical Study of Precision Chemoablation for Hypertrophic Obstructive Cardiomyopathy Without Large Interventricular Septal Branches
    Cao, Xinnan
    Huang, Rong
    Geng, Haihua
    Liu, Hu
    Gu, Yi
    Xu, Peishu
    Chen, Yufeng
    Yao, Jian
    Sheng, Hongzhuan
    CLINICAL CARDIOLOGY, 2025, 48 (03)
  • [48] Mid-Term Outcomes of Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy in Patients With Sigmoid Versus Neutral Ventricular Septum
    Veselka, Josef
    Tomasov, Pavol
    Zemanek, David
    JOURNAL OF INVASIVE CARDIOLOGY, 2012, 24 (12): : 636 - 640
  • [49] Mid-term Outcomes of Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy in Patients with Sigmoid versus Neutral Ventricular Septum
    Veselka, Josef
    Tomasov, Pavol
    Zemanek, David
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (17) : B222 - B222
  • [50] Molecular determinants of ventricular septal defects in Down syndrome
    Olakanpo, OD
    PEDIATRIC RESEARCH, 2004, 55 (04) : 53A - 53A